Three-drug combination helps curb the growth of deadly type of skin cancer

Source: ECancer News, July 2019

A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.

The approach shows promise for extending the lives of people with a type of melanoma that contains a potent gene mutation, BRAF V600E.

In clinical trials, it appeared not to cause the debilitating side effects that are caused by a combination of one targeted drug and an immunotherapy drug.